Voriconazole
-
API Product :
Voriconazole
-
CEP :
¤
-
WCC :
?
-
Therapeutic Use :
Systemic antibacterials; Ophthalmologicals; Systemic agents for fungal infections
-
Originator :
Pfizer
-
CAS No. :
137234-62-9
-
Trade Name. :
VFEND
-
Molecular Weight :
349.311 g/mol
-
Molecular Formula :
C16H14F3N5O
Application
It is also used to treat esophageal candidiasis (a yeast [a type of fungus] infection that may cause white patching in the mouth and throat) and other yeast infections of the skin, stomach, kidney, bladder, and wounds. Voriconazole is in a class of antifungal medications called triazoles.
General Description
Voriconazole, sold under the brand name Vfend among others, is an antifungal medication used to treat a number of fungal infections.[3] This includes aspergillosis, candidiasis, coccidioidomycosis, histoplasmosis, penicilliosis, and infections by Scedosporium or Fusarium.[3] It can be taken by mouth or used by injection into a vein.[3] Common side effects include vision problems, nausea, abdominal pain, rash, headache, and seeing or hearing things that are not present.[3] Use during pregnancymay result in harm to the baby.[3] It is in the triazole family of medications.[3] It works by affecting the cell membrane or affecting fungal metabolism.